Authorized purpose: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
Clinical role
Post-processing image enhancement for adjunctive line, tube, and electrical-cardiac-wire confirmation and localization.
Images and patients
X-ray/Radiography · Chest, including lines, tubes, and electrical cardiac wires
Key limitation
Keep in mind: The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest, including lines, tubes, and electrical cardiac wires Input: AP or PA chest radiographs from patients with lines and tubes; the device is not intended for pediatric patients.
Who uses it?Intended users: Trained professionals such as physicians, radiologists, and technicians
What does the software produce?Output: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
What is its most important limitation?Key limitation: The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.
Clinical takeaway. Clinical role: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
Evidence takeaway. Evidence from the reviewed source record: Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.
Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
ClearRead +Confirm regulatory performance study summary
DesignReader Study
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K123526
IndependenceIndependence not established
K123526
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K123526. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: AP or PA chest radiographs from patients with lines and tubes; the device is not intended for pediatric patients.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The device shares a DICOM communication and system-configuration platform with ClearRead Bone Suppression and supports review, storage, printing, and distribution of DICOM-compliant images across hospital networks. A specific PACS/RIS interface or deployment model is not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-09 ·
Returned objects
Source context, not route validation: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The device shares a DICOM communication and system-configuration platform with ClearRead Bone Suppression and supports review, storage, printing, and distribution of DICOM-compliant images across hospital networks. A specific PACS/RIS interface or deployment model is not established.
The 510(k) summary states the ClearRead +Confirm device is intended to be used by trained professionals, such as physicians, radiologists, and technicians, on patients with lines and tubes, and is not intended for pediatric patients.
Exact FDA submission
Checked 2026-10-27
User qualification wording only; the summary specifies no training program or training offering for this device.
ACR AI Central provides an exact-submission model card for CLEARREAD +CONFIRM; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission
No public price or quote for the exact K123526 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-09 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-09 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: Concurrent CADe support for identifying, categorizing, and highlighting suspicious regions of interest in the Lungs, Pleura, Cardiac, and Hardware categories on chest radiographs for radiologist review.
Modality
X-ray/Radiography
Anatomy
Chest: lungs, pleura, cardiac structures, and hardware
Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.
Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.